Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews
Geun Joo Choi, Hyun Min Kim, Hyun Kang
Journal of Lipid and Atherosclerosis (2020) Vol. 9, Iss. 3, pp. 435-435
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Low HDL and high triglycerides predict COVID-19 severity
L. Masana, Eudald Correig, Daiana Ibarretxe, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 173
Introduction to Umbrella Reviews as a Useful Evidence-Based Practice
Geun Joo Choi, Hyun Kang
Journal of Lipid and Atherosclerosis (2023) Vol. 12, Iss. 1, pp. 3-3
Open Access | Times Cited: 50
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19
Sokratis A. Apostolidis, Amrita Sarkar, H.M. Giannini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
Indriwanto Sakidjan Atmosudigdo, Michael Anthonius Lim, Basuni Radi, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2021) Vol. 14
Open Access | Times Cited: 47
Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology
Margarita Villar, José Miguel Urra, Francisco J. Rodríguez‐del‐Río, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Matheus Antônio Souto de Medeiros, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 2, pp. 251-264
Open Access | Times Cited: 23
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 23
Clinical and immunological comparison of COVID-19 disease between critical and non-critical courses: a systematic review and meta-analysis
Mojtaba Hedayati-Ch, Hadi Sedigh Ebrahim‐Saraie, Arash Bakhshi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1743-1765
Open Access | Times Cited: 30
High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
Estefanía Alcántara-Alonso, Fernando Molinar-Ramos, Jesús Alberto González-López, et al.
Clinical Nutrition ESPEN (2021) Vol. 44, pp. 437-444
Open Access | Times Cited: 28
Metabolic syndrome enhances SARS-CoV-2 disease severity and reduces mRNA vaccine efficacy in a mouse model
Elizabeth Geerling, E. Taylor Stone, Danielle Carpenter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cholesterol, triglycerides, HDL, and nitric oxide as determinants of resting heart rate variability in non-hospitalized mild post-COVID individuals: a cross-sectional study
Lucivalda Viegas de Almeida, Aldair Darlan Santos‐de‐Araújo, Luís Cláudio Nascimento da Silva, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Wildeman Zapata, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 18
Development and validation of a hybrid deep learning–machine learning approach for severity assessment of COVID-19 and other pneumonias
Doohyun Park, Ryoungwoo Jang, Myung Jin Chung, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Are lipid ratios and triglyceride-glucose index associated with critical care outcomes in COVID-19 patients?
Marzieh Rohani-Rasaf, Kosar Mirjalili, Akram Vatannejad, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0272000-e0272000
Open Access | Times Cited: 15
Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis
Sergio Rico‐Martín, Julián Fernando Calderón García, Belinda Basilio-Fernández, et al.
Journal of Cardiovascular Development and Disease (2021) Vol. 8, Iss. 12, pp. 162-162
Open Access | Times Cited: 18
A novel NiVP/Pi-based flexible sensor for direct electrochemical ultrasensitive detection of cholesterol
Neha Thakur, Debaprasad Mandal, Tharamani C. Nagaiah
Chemical Communications (2022) Vol. 58, Iss. 16, pp. 2706-2709
Closed Access | Times Cited: 13
Effect of COVID-19 on lipid profile parameters and its correlation with acute phase reactants: A single-center retrospective analysis
Talal Almas, Jahanzeb Malik, Abdulla K. Alsubai, et al.
Annals of Medicine and Surgery (2022) Vol. 78
Open Access | Times Cited: 13
Alteration in Redox Status and Lipoprotein Profile in COVID-19 Patients with Mild, Moderate, and Severe Pneumonia
Miodrag Lalosevic, Jelena Kotur‐Stevuljević, Jelena Vekić, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 11
The Association between Dyslipidemia and Pulmonary Diseases
Hideaki Isago
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 9, pp. 1249-1259
Open Access | Times Cited: 2
Metabolic syndrome and aberrant immune responses to viral infection and vaccination: Insights from small animal models
Elizabeth Geerling, Muddassar Hameed, James Weger‐Lucarelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Dyslipidaemia and mortality in COVID-19 patients: a meta-analysis
Marco Zuin, Gianluca Rigatelli, Claudio Bilato, et al.
QJM (2020) Vol. 114, Iss. 6, pp. 390-397
Open Access | Times Cited: 15
Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case–control study
Shahab Changaripour, Hosna Sarvazad, Maryam Barghi, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 2, pp. 030006052210786-030006052210786
Open Access | Times Cited: 9
Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19
Sokratis A. Apostolidis, Amrita Sarkar, H.M. Giannini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top